These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15956348)
1. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain. Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348 [TBL] [Abstract][Full Text] [Related]
2. Cloning and activation of the bullfrog apelin receptor: Gi/o coupling and high affinity for [Pro1]apelin-13. Moon MJ; Oh DY; Moon JS; Kim DK; Hwang JI; Lee JY; Kim JI; Cho S; Kwon HB; Seong JY Mol Cell Endocrinol; 2007 Oct; 277(1-2):51-60. PubMed ID: 17825479 [TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of the bullfrog kisspeptin receptor GPR54 with high sensitivity to Xenopus kisspeptin. Moon JS; Lee YR; Oh DY; Hwang JI; Lee JY; Kim JI; Vaudry H; Kwon HB; Seong JY Peptides; 2009 Jan; 30(1):171-9. PubMed ID: 18550222 [TBL] [Abstract][Full Text] [Related]
4. Expression of neurotensin receptors in human corneal keratocytes. Bourcier T; Rondeau N; Paquet S; Forgez P; Lombet A; Pouzaud F; Rostène W; Borderie V; Laroche L Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1765-71. PubMed ID: 12036977 [TBL] [Abstract][Full Text] [Related]
6. Intermolecular cross-talk between NTR1 and NTR2 neurotensin receptor promotes intracellular sequestration and functional inhibition of NTR1 receptors. Hwang JR; Baek MW; Sim J; Choi HS; Han JM; Kim YL; Hwang JI; Kwon HB; Beaudet N; Sarret P; Seong JY Biochem Biophys Res Commun; 2010 Jan; 391(1):1007-13. PubMed ID: 19968961 [TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of chicken prostaglandin E receptor subtypes 2 and 4 (EP2 and EP4). Kwok AH; Wang Y; Wang CY; Leung FC Gen Comp Endocrinol; 2008 Jun; 157(2):99-106. PubMed ID: 18486942 [TBL] [Abstract][Full Text] [Related]
8. Phylogenetic history, pharmacological features, and signal transduction of neurotensin receptors in vertebrates. Hwang JI; Kim DK; Kwon HB; Vaudry H; Seong JY Ann N Y Acad Sci; 2009 Apr; 1163():169-78. PubMed ID: 19456337 [TBL] [Abstract][Full Text] [Related]
9. Common quantitative trait loci for alcohol-related behaviors and central nervous system neurotensin measures: hypnotic and hypothermic effects. Erwin VG; Markel PD; Johnson TE; Gehle VM; Jones BC J Pharmacol Exp Ther; 1997 Feb; 280(2):911-8. PubMed ID: 9023306 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of structure and tissue distribution of chicken neurotensin receptor. Numao M; Sudo H; Yamamoto I; Nakao N; Kaiya H; Miyazato M; Tsushima N; Tanaka M Gen Comp Endocrinol; 2011 Mar; 171(1):33-8. PubMed ID: 21199657 [TBL] [Abstract][Full Text] [Related]
11. Expression of neurotensin and its receptors in pituitary adenomas. Giorgi RR; Chile T; Bello AR; Reyes R; Fortes MA; Machado MC; Cescato VA; Musolino NR; Bronstein MD; Giannella-Neto D; Corrêa-Giannella ML J Neuroendocrinol; 2008 Sep; 20(9):1052-7. PubMed ID: 18624930 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a levocabastine-sensitive neurotensin binding site. Chalon P; Vita N; Kaghad M; Guillemot M; Bonnin J; Delpech B; Le Fur G; Ferrara P; Caput D FEBS Lett; 1996 May; 386(2-3):91-4. PubMed ID: 8647296 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice. Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157 [TBL] [Abstract][Full Text] [Related]
14. Characterization of functional neurotensin receptors on human lymphocytes. Evers BM; Bold RJ; Ehrenfried JA; Li J; Townsend CM; Klimpel GR Surgery; 1994 Aug; 116(2):134-9; discussion 139-40. PubMed ID: 8047978 [TBL] [Abstract][Full Text] [Related]
15. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247 [TBL] [Abstract][Full Text] [Related]
16. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa. Bradford CS; Walthers EA; Searcy BT; Moore FL J Mol Endocrinol; 2005 Jun; 34(3):809-23. PubMed ID: 15956349 [TBL] [Abstract][Full Text] [Related]
17. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
18. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. Pettibone DJ; Hess JF; Hey PJ; Jacobson MA; Leviten M; Lis EV; Mallorga PJ; Pascarella DM; Snyder MA; Williams JB; Zeng Z J Pharmacol Exp Ther; 2002 Jan; 300(1):305-13. PubMed ID: 11752130 [TBL] [Abstract][Full Text] [Related]
19. Cloning and distribution of the bullfrog type 1 and type 2 corticotropin-releasing factor receptors. Ito Y; Okada R; Noriyuki T; Kikuyama S Gen Comp Endocrinol; 2006 May; 146(3):291-5. PubMed ID: 16384555 [TBL] [Abstract][Full Text] [Related]
20. Neurotensin negatively modulates Akt activity in neurotensin receptor-1-transfected AV12 cells. Liu F; Yang P; Baez M; Ni B J Cell Biochem; 2004 Jun; 92(3):603-11. PubMed ID: 15156571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]